• The oral suspension is intended for oral administration of Nystatin in infants, young children and subjects with significant oral and pharyngeal candidiasis.
• Treatment of digestive candidiasis excluding esophageal candidiasis of The immunocompromised.
• Complementary Treatment of vaginal and cutaneous candidiasis, with The aim of obtaining sterilization of associated intestinal candidiasis.
• Prevention of candidiasis in high-risk subjects: premature babies, immunocompromised, patients subjected to antineoplastic chemotherapy.
There are no reviews yet.